PD-1 Antibody in Addition to BACE in Patients With NSCLC: A Randomised Controlled Trial

NCT05605613 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

DRUG: PD-1 Antibody
DEVICE: BACE

Sponsor

Xuhua Duan